Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis.

导出 LinkOut

翻译打印收藏纠错

作者： Alexander A,Stepanov ^[1] ; Kristina A,Malsagova ^[1] ; Arthur T,Kopylov ^[1] ; Vladimir R,Rudnev ^[1] ; Dmitry E,Karateev ^[2] ; Evgenia I,Markelova ^[2] ; Elena L,Luchikhina ^[2] ; Elena E,Borisova ^[2] ; Anna L,Kaysheva ^[1]

作者单位： Biobanking Group, Branch of IBMC "Scientific and Education Center", 109028 Moscow, Russia. ^[1] Moscow Regional Research and Clinical Institute ("MONIKI"), 129110 Moscow, Russia. ^[2]

关键词 ELISA HPLC-MS/MS inhibitors of IL6 inhibitors of TNF metabolome proteome rheumatoid arthritis

DOI 10.3390/life13020596

PMID 36836953

发布时间 2023-03-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Life (Basel, Switzerland)

2023年13卷2期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis.

Life (Basel, Switzerland)

相似文献

Life (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis.

Life (Basel, Switzerland)

相似文献

Life (Basel, Switzerland)

相关期刊

检索历史清除